Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-05-20
1994-03-15
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549510, 549511, A01N 4302, C07D30500
Patent
active
052946371
ABSTRACT:
This invention relates to a fluorinated taxol of formula I ##STR1## in which R.sup.1 is --COR.sup.z in which R.sup.z is RO-- or R;
REFERENCES:
patent: 4814470 (1989-03-01), Colin et al.
patent: 4876399 (1989-10-01), Holton et al.
patent: 4960790 (1990-10-01), Stella et al.
patent: 5015744 (1991-05-01), Holton et al.
patent: 5136060 (1992-08-01), Holton et al.
S. Cai, et al, "Application of Protease-Catalyzed Regioselective Esterification in Synthesis of 6'-Deoxy-6'-fluoro- and 6-Deoxy-6-fluorolactosides", J. Org. Chem., 57, No. 12, pp. 3431-3437, 1992.
G. I. Georg, et al, "Synthesis of Biologically Active Taxol Analogues with Modified Phenylisoserine Side Chains", Journal Of Medicinal Chemistry, 35, pp. 4230-4237, 1992.
G. I. Georg, et al, "Semisynthesis and Biological Activity of Taxol Analogues: Baccatin III 13-(N-benzoyl-(2'R,3'S)-3'-(p-tolyl)isoserinate), Baccatin III 13-(N-(p-toluoyl)-(2'R,3'S)-3'-phenylisoserinate), Baccatin III 13-(N-benzoyl-(2'R,3'S)-3'-(p-trifluoromethylphenyl)isoserinate), and Baccatin III 13-(N-(p-trifluoromethylbenzoyl)-(2'R,3'S)-e'-phenylisoserinate)", BIOORGANIC & MEDICAL CHEMISTRY LETTERS, 2, No. 12, pp. 1751-1754, 1992.
G. I. George, et al, "Novel Biologically Active Taxol Analogues: Baccatin III 13-(N-(p-Chlorobenzoyl)-2'R,3'S)-3'-phenylisoserinate) and Baccatin III 13-(N-Benzoyl-(2'R,3'S)-3'-(p-chlorophenyl)isoserinate)", BIOORGANIC & MEDICAL CHEMISTRY LETTERS, 2, No. 4, pp. 295-298, 1992.
F. Gueritte-Voegelein et al, "Relationships between the Structure of Taxol Analogues and Their Antimitotic Activity," JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34, pp. 992-998.
D. G. I. Kingston, et al, "The Chemistry of Taxol, A Clinically Useful Anticancer Agent", JOURNAL OF NATURAL PRODUCTS, 53, No. 1, pp. 1-12, 1990.
N. F. Magri and D. G. I. Kingston, "Modified Taxols, 2..sup.1 Oxidation Products of Taxol", J. ORG. CHEM., 51, pp. 797-802, 1986.
N. F. Magri and D. G. I. Kingston, "Modified Taxols, 4. Synthesis and Biological Activity of Taxols Modified in the Side Chain", JOURNAL OF NATURAL PRODUCTS, 51, No. 2, pp. 298-306, 1988.
W. P. McGuire, M. D. et al., "Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms," ANNALS OF INTERNAL MEDICINE, Aug. 15, 1989, III, No. 4, pp. 273-279.
I. Ojima, et al., "Efficient and Practical Asymmetric Synthesis of the Taxol C-13 Side Chain, N-Benzoyl-(2R,3S)-3-phenylisoserine, and Its Analogues via Chiral 3-Hydroxy-4-aryl-.beta.-lactams through Chiral Ester Enolate-Imine Cyclocondensation", J. ORG. CHEM., 56, pp. 1681-1683, 1991.
I. Ojima, et al., "New and Efficient Approaches to the Semisynthesis of Taxol and Its C-13 Side Chain Analogs by means of .beta.-Lactam Synthon Method", TETRAHEDRON, 48, No. 34, pp. 6985-7012, 1992.
C. S. Swindell et al., "Biologically Active Taxol Analogues with Deleted A-Ring Side Chain Substituents and Variable C-2' Configurations," JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34, pp. 1176-1184.
Chen Shu-Hui
Farina Vittorio
Kant Joydeep
Vyas Dolatrai M.
Bristol--Myers Squibb Company
Han William T.
Reamer James H.
LandOfFree
Fluoro taxols does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluoro taxols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluoro taxols will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1536322